| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.083 | 22.106 | 26.150 | 26.198 | 26.082 | 26.967 | 26.857 | 38.305 | 12.089 | 0 |
| Total Income - EUR | 23.083 | 22.106 | 26.150 | 26.198 | 26.082 | 26.967 | 26.926 | 38.305 | 12.089 | 0 |
| Total Expenses - EUR | 4.071 | 3.557 | 4.775 | 8.911 | 7.372 | 8.077 | 6.886 | 8.088 | 4.131 | 1.437 |
| Gross Profit/Loss - EUR | 19.011 | 18.549 | 21.375 | 17.286 | 18.711 | 18.890 | 20.040 | 30.217 | 7.958 | -1.437 |
| Net Profit/Loss - EUR | 18.319 | 17.886 | 20.477 | 16.500 | 17.928 | 18.173 | 19.384 | 29.408 | 7.861 | -1.437 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Medsim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.291 | 1.106 | 10.722 | 8.204 | 6.691 | 3.696 | 1.504 | 479 | 265 | 53 |
| Current Assets | 25.616 | 17.099 | 17.715 | 14.807 | 16.536 | 17.608 | 19.234 | 29.656 | 7.947 | 1.612 |
| Inventories | 0 | 0 | 913 | 0 | 91 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 25.038 | 15.705 | 10.699 | 1.411 | 2.445 | 1.961 | 6.331 | 24.767 | 5.093 | 0 |
| Cash | 578 | 1.395 | 6.103 | 13.396 | 14.001 | 15.647 | 12.903 | 4.890 | 2.854 | 1.612 |
| Shareholders Funds | 26.576 | 17.941 | 20.529 | 16.552 | 17.979 | 18.223 | 19.432 | 29.457 | 7.909 | 1.363 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 331 | 265 | 7.908 | 6.459 | 5.248 | 3.082 | 1.306 | 679 | 303 | 302 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medsim S.r.l.